The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback